MACKENZIE FINANCIAL CORP - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q4 2020$150,000
-77.0%
10,300
-86.2%
0.00%
-100.0%
Q2 2016$651,000
+65.2%
74,8000.0%0.00%0.0%
Q1 2016$394,000
-32.1%
74,8000.0%0.00%0.0%
Q4 2015$580,000
+9.0%
74,800
+10.7%
0.00%
+33.3%
Q3 2015$532,000
+2.5%
67,600
+18.0%
0.00%0.0%
Q2 2015$519,000
-30.2%
57,3000.0%0.00%
-25.0%
Q1 2015$744,000
+9.7%
57,300
+15.1%
0.00%
+33.3%
Q4 2014$678,000
+56.2%
49,800
+2.9%
0.00%
+50.0%
Q3 2014$434,00048,4000.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders